The Europe preoperative infection prevention & wound cleansing device market is expected to grow from US$ 471.59 million in 2021 to US$ 729.59 million by 2028. It is estimated to register a CAGR of 6.4% from 2021 to 2028.

Rising Incidence of Surgical Site Infections (SSIs) Drives Europe Preoperative Infection Prevention & Wound Cleansing Device Market Growth

Surgical Site Infection (SSI) is the most common nosocomial infection and a common side effect of gastrointestinal surgery. Gastrointestinal surgical procedures and wound closure methods influence the occurrence of superficial wound infections. There has been a rapid increase in simple incisional SSI infection cases than in deep incisional SSI and organ or space SSI cases. SSIs are treated with antibiotics; however, sometimes, additional procedures are needed to treat the infection. The rising geriatric population with compromised immunity and the increasing surgical procedures across Europe fuel the incidence of SSIs, which drives the growth of the Europe preoperative infection prevention & wound cleansing device market . SSIs place a significant clinical and economic burden on patients and the healthcare system due to increased morbidity, mortality, and hospital expenses. Prevention of SSIs requires surveillance activities leading to effective mitigation strategies. According to the CDC guidelines, SSI is classified into superficial incisional SSI, internal deep incisional SSI, and organ SSI. Contamination levels and surgical techniques have been identified as strong predictors of SSI occurrence. According to the Agency of Healthcare Research and Quality, SSIs occur in ~2 to 4% of all the patients that undergo inpatient surgical procedures. SSIs are the leading cause of readmission to the hospital after surgery, and about 3% of the patients that acquire SSIs die. Owing to the rising number of SSIs cases, the need for preoperative infection prevention is growing as hospitals and healthcare centers are opting for preoperative infection prevention procedures to prevent SSIs.

Europe Preoperative Infection Prevention & Wound Cleansing Device Market Overview

The European preoperative infection prevention & wound cleansing devices market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. According to the World Health Organization (WHO), surgical site infections are one of the most frequent nosocomial infections observed in Germany. Colon surgery is associated with such infections, accounting for over 7% of all surgeries. As a result, demand for minimally invasive surgical devices is likely to rise during the forecast period. The cases of diabetes are increasing in Germany, and diabetic patients are more likely to develop diabetic ulcers, which is anticipated to fuel the market growth in the coming year. According to the International Diabetes Federation in 2021, 6.20 million people had diabetes in Germany in 2021, which is expected to increase to 6.52 million by 2030. As a result, the demand for wound care biologics is expected to increase during the forecast period, which will drive the market growth in the coming years.

Europe Preoperative Infection Prevention & Wound Cleansing Device Market Revenue and Forecast to 2028 (US$ Million)

Europe Preoperative Infection Prevention & Wound Cleansing Device Market Segmentation

The Europe preoperative infection prevention & wound cleansing device market is segmented on the basis of product, surgery, application, and country.

Based on product, the Europe preoperative infection prevention & wound cleansing device market is bifurcated into preoperative infection prevention devices and preoperative wound cleansing devices. In 2021, the preoperative infection prevention devices segment registered a larger share in the Europe preoperative infection prevention & wound cleansing device market. The market for the preoperative infection prevention devices segment is further segmented into infection prevention supplies, medical waste disposable devices, and infection prevention equipment.

Based on surgery, the Europe preoperative infection prevention & wound cleansing device market is segmented into cataract surgery, cesarean surgery, gastric bypass, appendectomy, colectomy and colostomy, esophagectomy, biopsy, cholecystectomy, mastectomy, cosmetic surgery, and others. In 2021, the cosmetic surgery segment registered the largest share in the Europe preoperative infection prevention & wound cleansing device market.

Based on application, the Europe preoperative infection prevention & wound cleansing device market is segmented into preoperative hair removal, preoperative skin preparation, intraoperative wound irrigation solution, and others. In 2021, the preoperative hair removal segment registered the largest share in the Europe preoperative infection prevention & wound cleansing device market. The preoperative hair removal segment is further sub segmented into clippers, razors, and depilators. The market for the preoperative skin preparation segment is further segmented into single use and multiple use. The market for the intraoperative wound irrigation solution segment is subsegmented into detergents, antibiotic laden lavage, antiseptic agents, and sterile normal saline market.

Based on country, the Europe preoperative infection prevention & wound cleansing device market is segmented into the UK, Germany, France, Spain, Italy, and the Rest of Europe. In 2021, Germany registered the largest share in the Europe preoperative infection prevention & wound cleansing device market.

3M Co; Bactiguard AB; Becton Dickinson and Co; bioMerieux SA; Cardinal Health Inc; Careon Healthcare Solutions Pvt Ltd; Dynarex Corp; Getinge AB; Medline Industries Inc; and Steris Plc are the leading companies operating in the Europe preoperative infection prevention & wound cleansing device market.